Genomic Health to Launch NGS-based Somatic Cancer Mutation Detection Platform for Pharma Research | GenomeWeb

By Turna Ray

MOUNTAIN VIEW, Calif. –
Genomic Health is planning to release a next-generation sequencing based research platform able to detect somatic mutations in 189 commonly mutated genes.

Speaking at the Personalized Medicine World Conference held here this week, Joffre Baker, Genomic Health's chief scientific officer, said that the company will make the platform available to its clinical and pharma collaborators in "several months."

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The price of plane tickets can affect how scientists in different countries choose to collaborate with each other, NPR reports.

The Annals of Improbable Research has awarded the 2016 Ig Nobel Prizes.

Scientific American alleges that the FDA has been "arm-twisting journalists into relinquishing their reportorial independence."

In Science this week: a global genetic interaction map for Saccharomyces cerevisiae, and progress made in genomics, precision medicine, and therapeutics.